Not Yet RecruitingNCT06689787
Official study titleA Mobile Health Intervention to Improve Psychosocial Functioning in Veterans With Posttraumatic Stress Disorder and Depression Symptoms
This study isn't recruiting yet.
In Palo AltoDepression, PTSDInterventional studyAges 18+
- Countries
- United States
- Sponsor
- VA Office of Research and Development (Government agency)
Not Yet RecruitingNCT07062666
Official study titleA Multicentre Clinical Study of Near Infrared Functional Brain Imaging Combined With Eye Tracking Technique for the Auxiliary Diagnosis and Treatment Effect Prediction of Depression
This study isn't recruiting yet.
Location not clearly listedDepressionObservational studyAges 18–60
- Countries
- Sponsor
- Zhongda Hospital
Not Yet RecruitingNCT06977308
This study isn't recruiting yet.
Location not clearly listedSchizophreniaMedication studyAges 18–30
- Countries
- Sponsor
- New York State Psychiatric Institute
Not Yet RecruitingACTRN12612001046897
Official study titleEvaluation of clinical severity and psychological distress following job seekers' use of the online mental health treatment service, Anxiety Online
This study isn't recruiting yet.
Remote / onlineAnxiety, DepressionInterventional studyAges 18–65
- Countries
- Sponsor
- National eTherapy Centre and BPsyC eTherapy Research Unit, Swinburne University
Not Yet RecruitingACTRN12624001023549
Official study titleA non-randomised trial comparing personalised versus non-personalised versions of the Daily Growth parenting app for emotion regulation in parents/carers and their children aged 2-5 years
This study isn't recruiting yet.
In AustraliaMental healthInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- Deakin University
Not Yet RecruitingACTRN12613000867796
Official study titleThe effect of volitional slow eye closure (VSEC) and self-distraction on sleep latency in people with sleep-onset insomnia: A Pilot Study
This study isn't recruiting yet.
Multiple locations, including HeidelbergMental healthInterventional studyAges 18–45
- Countries
- Australia
- Sponsor
- Institute for Breathing and Sleep (IBAS)
Not Yet RecruitingACTRN12612000988853
Official study titleThe Future of Childhood Anxiety Treatment: Translating Cognitive-Neuroscience Insights into Clinical Practice
This study isn't recruiting yet.
Location not clearly listedAnxietyInterventional studyAges 7–13
- Countries
- Sponsor
- Dr Allison Waters
Not Yet RecruitingNCT07039903
Official study titleBridging the Gap in the Study of Bipolar Disorder and Attention Deficit Hyperactivity Disorder: Impact of cognitiVE Reserve and funCtioning in a Newly Designed Treatment intervenTion for comORbidity (VECTOR)
This study isn't recruiting yet.
In BarcelonaBipolarity, ADHDBehavioural studyAges 18+
- Countries
- Spain
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute
Not Yet RecruitingACTRN12623000352606
Official study titleCo-Design of a Novel Yoga-Mindfulness Intervention Targeting Anxiety Among Children with Autism Spectrum Disorder: A Randomised Control Trial
This study isn't recruiting yet.
In AustraliaAnxietyInterventional studyAges 6–18
- Countries
- Australia
- Sponsor
- Tundi Loftus
Not Yet RecruitingACTRN12626000169347
Official study titleA hybrid II implementation-effectiveness randomised controlled trial of a peer supported self-management intervention “My Personal REcovery Plan” (MyPREP-ED) for young people in Early Psychosis Services
This study isn't recruiting yet.
In AustraliaSchizophreniaInterventional studyAges 16+
- Countries
- Australia
- Sponsor
- The University of Sydney
Not Yet RecruitingNCT06980207
Official study titleA Phase 1, Randomized, Double-Blind, Placebo-Controlled, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral LPM526000133 Fumarate Capsules (LY03017) in Healthy Adult Subjects.
This study isn't recruiting yet.
In ShanghaiSchizophreniaMedication studyAges 18–45
- Countries
- China
- Sponsor
- Luye Pharma Group Ltd.
Not Yet RecruitingACTRN12626000909325
Official study titleA Phase 1, Open-label, Single-arm Basket Trial of Intravenously Administered Psilocin (TRP-8803) in Anorexia Nervosa, Fibromyalgia, Generalised Anxiety Disorder, Irritable Bowel Syndrome, Obsessive Compulsive Disorder, Post Traumatic Stress Disorder, and Treatment-resistant Major Depressive Disorder
This study isn't recruiting yet.
In AustraliaDepression, PTSD, ...Interventional studyAges 18–60
- Countries
- Australia
- Sponsor
- Tryptamine Therapeutics